Table 2.
Univariate analysis for factors associated to response to cyproheptadine.
| Variable | Responders | Non-responders | P value |
|---|---|---|---|
| Age | 0.03 | ||
| Children | 31/48 (65%) | 17/48 (35%) | |
| Adolescents | 13/32 (41%) | 19/32 (59%) | |
| Sex | 0.11 | ||
| Male | 12/28 (43%) | 16/28 (57%) | |
| Female | 32/52 (62%) | 20/52 (38%) | |
| Gastric emptying study | 0.22 | ||
| Normal | 20/29 (69%) | 9/29 (31%) | |
| Abnormal | 12/23 (52%) | 11/23 (48%) | |
| Antroduodenal manometry | 0.31 | ||
| Normal | 6/8 (75%) | 2/8 (25%) | |
| Abnormal | 8/15 (53%) | 7/15 (47%) | |
| Functional dyspepsia | 0.06 | ||
| Yes | 20/44 (45%) | 24/44 (55%) | |
| No | 24/36 (67%) | 12/36 (33%) | |
| Vomiting | 0.18 | ||
| Yes | 12/27 (44%) | 15/27 (56%) | |
| No | 32/53 (60%) | 21/53 (40%) | |
| Cyproheptadine | 0.11 | ||
| First therapy | 33/54 (61%) | 21/54 (39%) | |
| After failed prokinetic therapy | 11/26 (42%) | 15/26 (58%) |